CanSino Biologics CEO Discusses First-Half Results and Vaccine Pipeline

Chairman and CEO Xuefeng Yu outlined the Chinese biotech firm's financial performance for the first half of the year and provided updates on its clinical development roadmap during a Bloomberg interview.